Please login to the form below

Not currently logged in
Email:
Password:

Novartis’ Dr Esteban Pombo-Villar joins Oxford BioTherapeutics

Will head the UK biotech's new development operations in Switzerland

Dr Esteban Pombo Villar - Oxford BioTherapeuticsDr Esteban Pombo-Villar has left Novartis after 24 years to become chief operations officer of Oxford BioTherapeutics (OBT).

Dr Pombo-Villar will oversee the UK-based biotech's newly-created clinical development operations in Basel, Switzerland, as the company takes its therapeutic antibody and antibody drug conjugate (ADC) oncology programmes into clinical development.

During his time at Novartis Dr Pombo-Villar had several roles, the most recent of which was head of alliance management at the Novartis Institute for Biomedical Research (NIBR), where he focused creating and managing the company's collaborative efforts.

He initially joined Sandoz Neuroscience Research in 1988 to work on drug discovery projects and to investigate the potential of emerging technologies and remained at the company following Sandoz' merger with Ciba-Geigy in 1996 to form Novartis.

Dr Christian Rohlff, CEO of OBT, said: “I am very pleased to welcome Esteban to OBT and to officially open our new clinical operations site in Basel, Switzerland. Esteban's extensive executive leadership experience in the industry will bring considerable value to OBT as we advance our highly promising lead programmes into the clinic.”

4th May 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

The doctor will text you now: Why healthcare providers cannot underestimate the importance of communicating change
Healthcare communication needs to switch from ‘transmit’ to ‘receive’, listening to what patients need and embracing the plethora of communication tools wholeheartedly....
How to innovate and influence people in times of misinformation
The pandemic has shown that public trust in promising new medical technologies is far from a given. Senior Writer Tom Vandyck at StoneArch, a member of Fishawack delves into the...
Could femtech be the answer to the gender health gap?
Here, we discuss the phenomenon of femtech, an industry that puts women’s experiences of lifestyle and health front and centre. We highlight some of the major players in the industry,...